glp-1 appendicitis After Initiation of Mounjaro (Tirzepatide) | DMSO glp-1 appendicitis GLP-1 Intolerance and

Overactivates, the HPA axis disrupts circadian glucocorticoid secretion, induces hypertrophy of the adrenal gland, decreases its sensitivity, impairs pituitary-adrenal stress responses induces reductions in both food intake and body weight [170]

Because tirzepatide's half-life is slightly shorter, it clears marginally faster than semaglutide in the reverse direction, but this does not meaningfully change the washout guidance for sema-to-tirz switching

This includes assessment for nutritional deficiencies, progression of diabetic neuropathy, introduction of other medications, or development of comorbid conditions known to cause secondary RLS

Trends in Peptide Drug Discovery

Taking progress photos is another great way to visually document your journey